PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32652142-6	2020	Systemic treatment with GAL (1 mg/kg, s.c.), an allosteric potentiating ligand for the nicotinic acetylcholine receptor (nAChR) and a weak cholinesterase inhibitor, attenuated the enhancement of impulsivity and impairment of attention induced by PNE in mice.	Galantamine	24-27	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	87-119	
32652142-6	2020	Systemic treatment with GAL (1 mg/kg, s.c.), an allosteric potentiating ligand for the nicotinic acetylcholine receptor (nAChR) and a weak cholinesterase inhibitor, attenuated the enhancement of impulsivity and impairment of attention induced by PNE in mice.	Galantamine	24-27	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	121-126	
32652142-8	2020	The effects of GAL were blocked by an alpha 7 nAChR antagonist, methyllycaconitine (1 mg/kg, i.p.).	Galantamine	15-18	cholinergic receptor, nicotinic, alpha polypeptide 7	Mus musculus	38-51